RxDoctor Payments Data

Oluseyi Fadayomi

Anesthesiology · Annapolis, MDNPI 1194163824

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 74.0% of it on its own, with 47 other manufacturers making up the rest. Among anesthesiology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$115,481in general payments, 2019–2025

Across 1,121 payments — averaging $103.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$85K
  • Nevro Corp.$11K
  • Medtronic$7K
  • Abbott$3K
  • Relievant Medsystems, Inc.$1K
  • Spinal Simplicity, LLC$1K
  • plus $7K from 42 others

What the payments were for

  • Consulting fees$13,89012%
  • Speaking & faculty fees$59,00051%
  • Travel & lodging$14,97913%
  • Food & beverage$27,61124%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$115,481 in reported general payments places this provider in the 95th percentile of 953 anesthesiology providers in Maryland.

See all anesthesiology providers in Maryland

Medicare billing

Part B allowed, 2024
$494,611
Medicare patients
613
Services billed
9,543

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl17$11,024
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen377$10,701
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen305$7,766
Gabapentin646$7,083
Buprenorphine26$6,849
Oxycodone Hcl346$5,408
Ms ContinMorphine Sulfate12$4,182
Lidocaine48$3,896
Pregabalin185$3,768
Cyclobenzaprine Hcl314$2,882
Celecoxib186$2,601
Tramadol Hcl269$2,039
Diclofenac Sodium96$1,706
Acetaminophen-CodeineAcetaminophen With Codeine97$1,540
Tramadol Hcl ErTramadol Hcl21$1,289

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$218$11,02417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 953 anesthesiology providers in Maryland.

Other anesthesiology in Annapolis

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →